CD4 + iNKT cells, unlike their CD4- counterparts, can boost tumor growth by inhibiting the cytotoxicity of CD8 + T cells and promoting Th2 cytokine production in HCC [108, 109]. The gene discussed is CD4; the disease is hepatocellular carcinoma.